Publications by authors named "Yasuko Tada"

Claim this Profile
H
Highly immunogenic cancer cells require activation of the WNT pathway for immunological escape.
Yoshiko Takeuchi, Tokiyoshi Tanegashima, Eiichi Sato, Takuma Irie, Atsuo Sai, Yasuko Tada

Sci Immunol· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer immunotherapy with PI3K and PD-1 dual-blockade via optimal modulation of T cell activation signal.
Sho Isoyama, Shigeyuki Mori, Daisuke Sugiyama, Yasuhiro Kojima, Yasuko Tada

J Immunother Cancer· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blockade of EGFR improves responsiveness to PD-1 blockade in -mutated non-small cell lung cancer.
Eri Sugiyama, Yosuke Togashi, Yoshiko Takeuchi, Sayoko Shinya, Yasuko Tada

Sci Immunol· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PD-1 regulatory T cells amplified by PD-1 blockade promote hyperprogression of cancer.
Takahiro Kamada, Yosuke Togashi, Christopher Tay, Danbee Ha, Akinori Sasaki, Yasuko Tada

Proc Natl Acad Sci U S A· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting VEGFR2 with Ramucirumab strongly impacts effector/ activated regulatory T cells and CD8 T cells in the tumor microenvironment.
Yasuko Tada, Yosuke Togashi, Daisuke Kotani, Takeshi Kuwata, Eichi Sato

J Immunother Cancer· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical response to PD-1 blockade correlates with a sub-fraction of peripheral central memory CD4+ T cells in patients with malignant melanoma.
Yoshiko Takeuchi, Atsushi Tanemura, Yasuko Tada, Ichiro Katayama, Atsushi Kumanogoh

Int Immunol· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis